AR059555A1 - Metodos para el tratamiento de degeneracion macular y condiciones oculares relacionadas - Google Patents
Metodos para el tratamiento de degeneracion macular y condiciones oculares relacionadasInfo
- Publication number
- AR059555A1 AR059555A1 ARP070100697A ARP070100697A AR059555A1 AR 059555 A1 AR059555 A1 AR 059555A1 AR P070100697 A ARP070100697 A AR P070100697A AR P070100697 A ARP070100697 A AR P070100697A AR 059555 A1 AR059555 A1 AR 059555A1
- Authority
- AR
- Argentina
- Prior art keywords
- macular degeneration
- treatment
- methods
- eye conditions
- related eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Abstract
Un complejo AIM-lípido para tratar la degeneracion macular relacionada con el envejecimiento y condiciones relacionadas. Las composiciones y los métodos abarcan un nuevo enfoque para el tratamiento de degeneracion macular relacionada con el envejecimiento y condiciones relacionadas. También se proveen composiciones farmacéuticas para este uso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77433106P | 2006-02-17 | 2006-02-17 | |
US77591506P | 2006-02-22 | 2006-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR059555A1 true AR059555A1 (es) | 2008-04-09 |
Family
ID=38437932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070100697A AR059555A1 (es) | 2006-02-17 | 2007-02-16 | Metodos para el tratamiento de degeneracion macular y condiciones oculares relacionadas |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070254832A1 (es) |
JP (1) | JP2007269778A (es) |
AR (1) | AR059555A1 (es) |
TW (1) | TW200808335A (es) |
WO (1) | WO2007098122A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2279730B1 (es) * | 2006-02-14 | 2008-08-01 | Italfarmaco, S.A. | Uso de derivados del acido sulfonico en el tratamiento de enfermedades vasoproliferativas oculares. |
EA201290442A1 (ru) * | 2009-12-04 | 2012-11-30 | Юклид Системз Корпорэйшн | Композиция и способы профилактики и лечения макулярной дегенерации, диабетической ретинопатии и диабетического макулярного отека |
CA2803031C (en) | 2010-06-30 | 2021-06-22 | Csl Limited | A reconstituted high density lipoprotein formulation and production method thereof |
AR082644A1 (es) * | 2010-08-30 | 2012-12-19 | Hoffmann La Roche | Tetranectina-apolipoproteina a-i, particulas lipidicas que la contiene y utilizacion de la misma relacionado con el metabolismo de los lipidos y las enfermedades cardiovasculares |
KR101424217B1 (ko) | 2011-05-18 | 2014-08-13 | 다이아텍코리아 주식회사 | 노년 황반변성의 진단, 치료 및 예방용 조성물 및 노년 황반변성에 대한 정보를 얻기 위한 방법 |
RU2014108240A (ru) | 2011-08-25 | 2015-09-27 | Ф. Хоффманн-Ля Рош Аг | Укороченный тетранектин-аполипопротеин а-i гибридный белок, содержащая его липидная частица и их применения |
US9125943B2 (en) * | 2012-11-02 | 2015-09-08 | Csl Limited | Reconstituted HDL formulation |
WO2017053346A1 (en) * | 2015-09-21 | 2017-03-30 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulations |
WO2017222042A1 (ja) * | 2016-06-24 | 2017-12-28 | 国立大学法人京都大学 | 眼用医薬組成物 |
US10426817B2 (en) * | 2017-01-24 | 2019-10-01 | Macregen, Inc. | Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics |
KR20190124704A (ko) * | 2017-01-24 | 2019-11-05 | 마크레젠, 인크. | 아포지질단백질 모방체를 이용하는, 나이 관련 황반 변성 및 기타 안질환의 치료 |
CA3057438A1 (en) | 2017-03-20 | 2018-09-27 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulaitons |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9103701D0 (sv) * | 1991-12-13 | 1991-12-13 | Kabi Pharmacia Ab | Apolipoprotein |
SE9203753D0 (sv) * | 1992-12-11 | 1992-12-11 | Kabi Pharmacia Ab | Expression system for producing apolipoprotein ai-m |
US5824685A (en) * | 1995-02-01 | 1998-10-20 | The Johns Hopkins University School Of Medicine | Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
JP3257391B2 (ja) * | 1996-03-18 | 2002-02-18 | 東洋インキ製造株式会社 | インクジェット記録液 |
SE9603304D0 (sv) * | 1996-09-11 | 1996-09-11 | Pharmacia & Upjohn Ab | Process for purifying a compound |
US6004925A (en) * | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6037323A (en) * | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6046166A (en) * | 1997-09-29 | 2000-04-04 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6287590B1 (en) * | 1997-10-02 | 2001-09-11 | Esperion Therapeutics, Inc. | Peptide/lipid complex formation by co-lyophilization |
DE10141018A1 (de) * | 2001-08-22 | 2003-03-13 | Eth Zuerich Eidgenoessische Te | Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges |
EP1438060B1 (en) * | 2001-09-28 | 2015-11-11 | Esperion Therapeutics Inc. | Prevention and treatment of restenosis by local administration of drug |
US7470659B2 (en) * | 2001-12-07 | 2008-12-30 | The Regents Of The University Of California | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
CA2485989A1 (en) * | 2002-05-17 | 2003-11-27 | Esperion Therapeutics, Inc. | Methods and compositions for the treatment of ischemic reperfusion |
PE20050438A1 (es) * | 2003-10-20 | 2005-06-14 | Esperion Therapeutics Inc | Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos |
US7427662B2 (en) * | 2005-02-01 | 2008-09-23 | Baord Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein |
-
2007
- 2007-02-15 US US11/707,809 patent/US20070254832A1/en not_active Abandoned
- 2007-02-16 AR ARP070100697A patent/AR059555A1/es unknown
- 2007-02-16 TW TW096106247A patent/TW200808335A/zh unknown
- 2007-02-16 JP JP2007036660A patent/JP2007269778A/ja active Pending
- 2007-02-16 WO PCT/US2007/004299 patent/WO2007098122A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
TW200808335A (en) | 2008-02-16 |
WO2007098122A3 (en) | 2008-07-03 |
WO2007098122A2 (en) | 2007-08-30 |
JP2007269778A (ja) | 2007-10-18 |
US20070254832A1 (en) | 2007-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR059555A1 (es) | Metodos para el tratamiento de degeneracion macular y condiciones oculares relacionadas | |
CY1120741T1 (el) | Θεραπεια οζωδους σκληρυνσης | |
SV2010003662A (es) | Derivados de azetidina y ciclobutano como inhibidores de jak ref. x-19081 | |
CL2008003096A1 (es) | Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras. | |
CL2014000032A1 (es) | Compuestos derivados de bencilamina, inhibidores de calicreina plasmatica; composicion farmaceutica; y su uso para el tratamiento de agudeza visual deteriorada, retinopatia diabetica, edema macular diabetico, hipotension cardiomiopatia, cancer, entre otros | |
CL2008001259A1 (es) | Uso de una composicion que comprende un inhibidor del factor d del complemento para preparar un medicamento util para la inhibicion de la perdida de agudeza visual ociada con la degeneracion macular relacionada con la edad. | |
SMT201600144B (it) | Nuovi derivati eterociclici e loro uso nel trattamento di disturbi neurologici | |
UY34220A (es) | Indazoles, composiciones farmacéuticas y uso de los mismos | |
CL2013001891A1 (es) | Compuestos heterociclicos fusionados; composicion farmaceutica y uso en el tratamiento de la degeneracion macular asociada con la edad. | |
CR20110216A (es) | Derivados de ácido 1-amino-2-ciclobutiletilborónico | |
UY34278A (es) | Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades | |
ECSP088590A (es) | Derivados de aminoácido multicíclicos y sus métodos de uso | |
ECSP078013A (es) | Inhibidores heterocíclicos de mek y métodos de uso de ellos | |
CO6501189A2 (es) | Derivados de oxazina y su uso en el tratamiento de los trastornos neurológicos | |
BR112013028666A2 (pt) | compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo | |
CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
ECSP10010112A (es) | Compuestos de tienopirimidina y pirazolopirimidina y su uso como inhibidores de mtor cinasa y pi3 cinasa | |
ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
UY31806A (es) | Compuestos de tiazole y oxazole de sulfonamida de benceno | |
CR11199A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
UY34350A (es) | Derivados de pirazolquinolinona, su preparación y su uso terapéutico. | |
UY34545A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios. | |
SV2010003559A (es) | Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrofilos | |
UY30304A1 (es) | Moduladores de mglur5 i | |
AR071120A1 (es) | Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |